بررسی عوامل خطر بر زمان بقای لوسمی حاد کودکان با استفاده از مدل ریسک رقابتی
Authors
Abstract:
Background and purpose: Acute leukemia is a malignancy with a rapidly progressive course of the lymphoid or myeloid cells. A prognostic factor for its survival and treatment is of particular importance in medical research. Therefore, this study aimed at applying competing risk model to compare clinical and pathologic factors in pediatric acute leukemia. Materials and methods: A historical cohort analysis was performed on survival data of 97 children with acute leukemia collected from Pediatric Oncology Department in Booali Sina Hospital in Sari from 2006 to 2014. We recorded data including age at diagnosis, type of leukemia, sex, white blood cell count, and platelet count. Statistical analysis using competing risk model, Cox regression model and STATS software were performed. Results: The median follow-up period was 14.83 mounts during which 27 patients (27.83%) (17 ALL cases and 10 AML cases) passed away. In competing risk model significant relationship was found between type of leukemia, hemoglobin count and white blood cell count with survival time. Conclusion: In order to identify the prognostic risk factors on the survival of patients with acute leukemia, in presence of competing risks, using the competing risk regression model was found more efficient compared to cox regression model.
similar resources
تعیین عوامل موثر بر بقای کودکان مبتلا به لوسمی لنفوبلاستیک حاد با استفاده از مدل خطرات رقیب
Background and Objective: Acute lymphoblastic leukemia (ALL) is the most common malignancy in children, accounting for about a quarter of all malignancies. This study aimed to identify the prognosis of patients with relapsed acute lymphoblastic leukemia in Dr. Sheikh Hospital in Mashhad from 2006 to 2015 using competing risk models. Materials and Methods: Patients with ALL from March 2006 to...
full textکاربرد مدل ریسک رقابتی در شناسایی عوامل موثر بر زمان بقای بیماران مبتلا به سرطان کولورکتال
Background and Objective: Colorectal cancer is the most common cancer of digestive system in Iran.The incidence of this cancer has increased in recent years.The aim of this study was to evaluate the survival rate and to define the prognostic factors in Iranian colorectal cancer patients using competing risk model. Materials and Methods: Data recorded from 1060 patients with colorectal cancer...
full textبررسی بقای بیماران مبتلا به سرطان کولورکتال با استفاده از مدل ریسک رقابتی پارامتری
Background and Objective: Colorectal cancer is the most common cancer of digestive system in Iran. The incidence of this cancer has increased in recent years.The aim of this study was to evaluate the survival rate and to define the prognostic factors in Iranian colorectal cancer patients using competing risk model. Materials and Methods: Data were recorded from 1060 patients with colorec...
full textبررسی عوامل خطر و شایع ترین تظاهرات بالینی شروع لوسمی لنفوبلاستیک حاد در کودکان
Background: The factors involve in Leukemia are not fully understood. However, research has shown the relationship between this disorder and some risk factors. The aim of this study was to determine risk factors involved in acute lymphoblastic leukemia and its most prevalent clinical manifestations in children residing in Khorasan province. Materials and Methods: It was a case – control stu...
full textبررسی بقای بیماران مبتلا به سرطان کولورکتال با استفاده از مدل ریسک رقابتی پارامتری
مقدمه و هدف: سرطان کولورکتال یکی از شایع ترین سرطان های دستگاه گوارش در ایران نیز می باشد. در سال های اخیر میزان بقای این سرطان افزایش داشته است؛ بنابراین هدف این مطالعه برآورد بقا و تعیین عوامل مؤثر بر بقای بیماران مبتلا به سرطان کولورکتال با استفاده از مدل ریسک رقابتی پارامتری است. مواد و روش ها: در این تحقیق از اطلاعات 1060 بیمار مبتلا به سرطان کولورکتال ثبت سرطان مرکز تحقیقات گوارش و کبد دا...
full textMy Resources
Journal title
volume 24 issue 121
pages 31- 38
publication date 2015-02
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023